Early－Phase Drug Development Service:
Phase I Clinical Trials Program

LatestNews

• 

  202602/17

  PF-08634404 (Pfizer) Global First Subject First Dose at First-in-Human Phase 1 Study

  View More

• 

  202512/08

  ABBV-711 (AbbVie) Global First Subject First Dose at First-in-Human Phase 1 Study

  View More

• 

  202511/27

  GSK5460025 (GlaxoSmithKline) Global First Subject First Dose at First-in-Human Phase...

  View More